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Abstract
Background: The inflammatory response to hepatic ischemia-reperfusion (I/R) is associated with
an increase in cytokine production. Studies have documented that sex hormones modulate both
the innate and adaptive immune responses, and that females are more robust than males. The aim
of this study was to determine whether a sex difference in cytokine response to hepatic I/R exists
under normal pathophysiologic condition without hormone intervention.
Methods:  Adult C57BL/6 mice underwent 90 min of hepatic ischemia followed by various
reperfusion periods (0, 1.5, 3, 6 hr). Plasma cytokine TNF-α, IL-6, MIP-2, and KC were measured.
Liver injury was assessed by plasma alanine transaminase (ALT) levels and liver histopathology.
Results: A reperfusion time-dependent increase in hepatocellular injury was observed in both
males and females, as indicated by increasing levels of plasma ALT and liver histopathology. The
plasma cytokines were significantly increased in both female and male I/R groups compared to their
respective sham counterparts. However, there was a significant difference in cytokine kinetics
between the female and male I/R groups. Female mice initially had a higher level of IL-6, KC, and
MIP-2 in response to I/R, which began to decline after 3 hr of reperfusion and were significantly
lower than the male I/R counterparts by 6 hr of reperfusion. In contrast, the hepatocellular injury
and TNF production were only moderately lower in female IR than male IR.
Conclusion: The study underscores role of the gender in differential inflammatory cytokine
expression in response to hepatic I/R, which may reflect the host response outcome.
Background
Hepatic ischemia/reperfusion (I/R) injury occurs when
there is a disruption of the blood flow to the liver fol-
lowed by restoration of blood flow. This injury usually
manifests itself during hepatic surgery, transplantation,
trauma and hemorrhagic shock, and can lead to liver
injury. Hepatic I/R injury is exemplified by a biphasic pat-
tern – the early phase is characterized by Kupffer cell acti-
vation, release of pro-inflammatory cytokines, and the
generation of reactive oxygen species (ROS), while the late
phase is characterized by a massive neutrophil infiltration
and further production of the inflammatory mediators
[1].
Although it is known that cytokines, neutrophils and ROS
play a role in mediating the inflammatory response dur-
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ing I/R injury, the exact mechanism has yet to be eluci-
dated. It is believed that Kupffer cells, which are the largest
fixed population of macrophages in the body, play an
important role in initiating a pro-inflammatory response
by way of cytokine and ROS production.
There is increasing evidence that a sex difference exists in
regard to inflammatory response and that this difference
may be attributed to the sex steroids. Although the exact
mechanism by which these steroids act in regard to
inflammation is unknown, it has been suggested that tes-
tosterone has immunosuppressive effects while estrogen
has immunoprotective effects [2]. Specifically, estrogen
has been shown to have anti-inflammatory properties,
strong anti-oxidative actions, and can stimulate the anti-
oxidant defense system thereby protecting tissues from
oxidative damage [3]. Studies have shown that not only
do females with sepsis have a lower mortality than male
patients with sepsis, but that females also have a better
prognosis. In particular, it has been found that male gen-
der provides a risk factor for sepsis [4] and that treatment
with estrogen has a protective effect [5]. Furthermore, it
has been demonstrated that women who developed sepsis
following surgical treatment had a higher level of IL-10
and a lower level of TNF-α compared to men [6]. Moreo-
ver, there has been increasing evidence indicating that
menopause is associated with an increase in proinflam-
matory cytokines such as IL-1, IL-6 and TNF-α [7,8] and
that treatment with estrogen has been shown to inhibit
these cytokines [9].
Gender dimorphism has also shown a role in hepatic
injury [10]. In a study by Harada et al. it was found that
female mice had a better survival rate than their male
counterparts in a model of hepatic I/R with liver reduction
(i.e. hepatectomy) [11]. Additionally, male mice treated
with estradiol not only showed an improved survival rate
after hepatic I/R, but also showed a decrease in liver injury
compared to their male control counterparts. Inaba et al.
showed that ovariectomized female rats subjected to
hepatectomy followed by administration of lipopolysac-
charide had a reduced survival rate compared to their
matched female counterparts, further supporting the
notion that sex steroids may play a role in hepatic injury
[12].
Studies noted above underscore the role of gender in
experimental inflammatory tissue injury by applying var-
iations of sex hormone interventions (i.e., administration
of sex hormone, ovariectomy, etc.), in which one has con-
trol over the sex hormone levels in the experimental set-
tings. The current study was undertaken to examine the
role of gender dimorphism in hepatic I/R inflammatory
response under normal pathophysiologic condition with-
out any artificial hormone intervention. In particular, the
aim was to determine whether gender difference played a
role in cytokine regulation in hepatic IR. The results indi-
cated a significant difference in cytokine regulation in
response to hepatic I/R between males and females, and
that the cytokine network is not the sole modulator of the
hepatocellular injury during early phase of hepatic I/R
injury.
Methods
All chemicals were purchased from the Sigma Chemical
Co. (St. Louis, MO), unless otherwise noted.
Experimental animal model of hepatic ischemia and 
reperfusion
All animals received humane care in compliance with the
Guide for the Care and Use of Laboratory Animals
(National Institutes of Health Publication No. 85–23,
revised 1985). Experimental protocols were reviewed and
approved by the Michigan State University Animal Use
and Care Committee. Adult (8–10 wk) male and female
C57BL/6 mice (Charles River Laboratories, Portage, MI)
weighing between 21–27 g were fed a standard diet and
acclimated in the animal housing area for 1 week before
experimentation. The mice were randomly divided into
three groups – the test group, the sham group, and the
control group. The test group underwent I/R, while the
sham group underwent the same surgical protocol but
without vascular occlusion to induce IR. No surgical pro-
cedure was performed on the control group. A model of
partial hepatic I/R as previously described by our labora-
tory was applied [13,14]. This model induces severe
ischemic insult to the liver without inducing hypertension
and subsequent bacterial translocation into the portal
venous blood. The mice were lightly anesthetized with
inhaled methoxyflurane (Baxter Caribe, Inc., Guayama,
PR), followed by an i.p. injection of 35 mg/kg sodium
pentobarbital (Abbott Laboratories, North Chicago, IL). A
midline laparotomy was performed, the portal circulation
to the median and left lateral lobes of the liver was care-
fully dissected, and an atraumatic vascular clip (Accurate
Surgical and Scientific Instruments Corp. Westbury, NY)
was placed on the vessels, interrupting the portal venous
and hepatic arterial blood supply to these lobes. The
abdomen was temporarily closed with sterile staple
sutures to prevent dehydration and possible contamina-
tion. After 90 min of partial hepatic ischemia, the clamp
was removed and reperfusion resumed. The abdomen was
closed in a double layer using 5-O nylon, and 0.8 ml ster-
ile lactated Ringer's Solution (Abbott Laboratories, North
Chicago, IL) was administered subcutaneously to com-
pensate for operative fluid loss. During the reperfusion,
the mice were kept in clean cages with no further admin-
istration of anesthesia or analgesics. After reperfusion,
mice were euthanized, and blood and tissue samples were
collected, as described below.Journal of Inflammation 2006, 3:16 http://www.journal-inflammation.com/content/3/1/16
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All the surgical procedures were performed under aseptic
conditions. In this model, the caudate and right lateral
lobes, as well as the papillary and quadrate processes,
retained an intact portal and arterial inflow and venous
outflow to prevent intestinal venous congestion. This
resulted in the induction of ischemia to approximately
70% of the liver. This hepatic IR model with 90 min of
ischemia induces a severe, isolated, and reproducible liver
injury with very minimal animal mortality within 2 weeks
of the injury (i.e. 0–5%).
Peripheral blood and tissue procurement
Blood samples were obtained from the right ventricle via
a left anterior thoracotomy at the time of euthanasia. The
blood was collected in a sterile syringe containing 50 μl of
heparin (100 USP Units/ml), and centrifuged to separate
the plasma. The plasma samples were stored at -70°C
until use for cytokine and ALT assays. A portion of the
ischemic and non-ischemic liver lobes were fixed in buff-
ered 10% formalin, embedded in paraffin, and used for
hematoxylin and eosin (H&E) staining. Another portion
of ischemic and non-ischemic liver lobes was frozen in
optimal cutting temperature compound (OTC media)
and stored at -70°C until use for cryosection preparation
and immunohistochemistry staining.
Measurement of plasma alanine aminotransferase levels
The plasma ALT levels were determined spectraphotomet-
rically, as previously described [13]. The ALT values are
expressed in international units per liter (IU/L).
Histopathology
H&E staining was performed on tissue sections prepared
at 5-μm intervals from paraffin-embedded liver tissue. A
pathologist, blinded to the experimental conditions,
examined the liver tissue sections.
Plasma cytokine concentrations
Plasma TNF-α, IL-6 and MIP-2 were determined in a 96-
well Nunc-Immuno microplate (VWR Scientific, Chicago,
IL), using a sandwich enzyme-linked immunosorbent
assay (ELISA) technique, as previously described [13]. The
capture antibody was a polyclonal anti-mouse TNF-α, IL-
6, KC, or MIP-2 specific goat IgG (R&D Systems, Minne-
apolis, MN) and the detection antibody was a bioti-
nylated polyclonal anti-mouse TNF-α, IL-6, KC or MIP-2
specific goat IgG, (R&D Systems). All plasma samples
were tested in duplicate. The minimal detectable protein
concentration was 20 pg/ml.
Determination of hepatic neutrophil accumulation by 
immunohistochemistry
To confirm the presence of neutrophils in the liver tissue,
immunohistochemical staining was performed using 5-
μm thick liver tissue section. The primary antibody (clone
7/4, IgG2a) specific to mouse neutrophils (Cedarlane,
Westbury, NY), the biotin-conjugated secondary antibody
(PharMingen, San Diego, CA), and Vectastain avidin-
biotin complex reagent and 3,3'-diaminobenzidine chrso-
mogen kits (Vector Laboratories, Inc., Burlingame, CA)
were used as previously described in detail [14]. A
matched antibody isotype immunoglobulin (IgG) was
applied as a negative control antibody to monitor the
anti-neutrophil antibody specificity. Tissue sections were
counter stained with hematoxylin (Gill's formula, Vector
Laboratories) and mounted with DAKO Mounting Media
(DAKO Corp, Carpinteria, CA). The samples were exam-
ined using a Nikon light microscope interfaced with a spot
24-Bit Digital Color Camera.
Statistical analysis
The data is expressed as means ± standard error of the
mean (SEM). Comparisons between two groups were per-
formed using an unpaired t-test. Comparisons between
multiple groups and various time points were analyzed
using ANOVA followed by a Fisher's PLSD post-hoc test. P
≤ 0.05 was considered statistically significant. All data was
analyzed using the StatView version 5.0.1 software © for
Windows.
Results
Demonstration of hepatic injury by determination of ALT 
levels and histopathology
Ninety min. of hepatic ischemia followed by reperfusion
caused hepatocellular injury in a time-dependent fashion,
as demonstrated by plasma ALT levels (Figure 1A). Signif-
icant hepatocellular injury occurred at 1.5, 3, and, 6 hrs of
reperfusion in both male and female I/R mice compared
to their respective sham equivalents (Figure 1A). There
was no significant increase in hepatocellular injury at the
onset of reperfusion (i.e. at time 0 of reperfusion), indicat-
ing that reperfusion played a critical role in the liver
injury. This level of injury at 0 hrs of reperfusion was sim-
ilar to those observed in sham and non-operated control
groups (Figure 1A and 1B). The female I/R mice at 3 and
6 hrs of reperfusion consistently showed lower levels of
plasma ALT than their respective male counterparts,
although this difference did not reach a statistical signifi-
cance (Figure 1A, p = 0.4). Further, histopathology exam-
ination confirmed hepatic injury, as was evident by
sinusoidal congestion, cytoplasmic vacuolization, hepa-
tocellular necrosis, and neutrophil infiltration. After 1.5,
3, and, 6 hrs of reperfusion, heaptocellular injury was
present and the injury was maximal by 6 hrs of reper-
fusion (Figure 2A, and 2B). There was sparing of the peri-
portal areas with progressive increased injury observed
approaching the central vein. There was no evidence of
hepatic injury due to ischemia alone, and the tissue his-
topathology was similar to that of sham and nonoperated
control groups (Figure 2C)Journal of Inflammation 2006, 3:16 http://www.journal-inflammation.com/content/3/1/16
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Time-course of plasma ALT levels following hepatic I/R Figure 1
Time-course of plasma ALT levels following hepatic I/R. Mice were subjected to 90 min. of ischemia followed by reper-
fusion with various lengths of time. "Control" indicates mice that underwent no surgical procedure. "Sham" indicates mice that 
underwent surgical procedure with no vascular occlusion followed by reperfusion, while "I/R" denote mice that underwent I/R 
surgical procedure. Values are expressed as mean ± SEM. *P < 0.05 female group vs. male group (n = 6–9 mice per each time 
point/group). A: I/R group; B: Sham group.
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Liver histopathology following hepatic I/R Figure 2
Liver histopathology following hepatic I/R. Mice were subjected to surgical procedure involving 90 min of ischemia fol-
lowed by 6 hrs of reperfusion, and the liver sections were then prepared and stained with H&E. Images were obtained with a 
10× and 40× objective lenses. Rows A and B correspond to the ischemic liver sections, while row C corresponds to the non-
ischemic liver of the same animal subjected to hepatic I/R. There is a significant amount of ischemic damage, as is evident by the 
loss of hepatocytes in the pericentral and midzonal areas, with relative sparing of the periportal areas (Rows A and B). Neu-
trophils are present in the midzonal region around the central vein. The non-ischemic liver sections show normal histology 
(Row C). Images are representative of 6–9 liver samples per each time point/group. Abbreviations: I = ischemic liver, NI = non-
ischemic liver.
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An immunohistochemical technique was applied to con-
firm the infiltrated neutrophils in the liver tissue by using
a specific antibody to mouse neutrophil. A marked
increase in neutrophil infiltration was not observed until
after 90 min. of ischemia followed by 6 hrs of reperfusion
(Figure 3A, and 3B). Although neutrophil trafficking into
the ischemic liver appeared to be more intense in male
mice than the female counterparts, the overall analysis did
not indicate a significant difference between the two
groups (sample size of eight mice per each group). There
was a minimal neutrophil infiltration into the non-
ischemic lobe of the IR animals indicating that the local
ischemic insult and not that of circulating cytokines/
chemokines played a major role in neutrophil trafficking
(Figure 3C). Neutrophil infiltration into the ischemic liver
at early time-points of reperfusion (i.e., 0, 1.5 and 3 hr)
was minimal (images not shown).
Plasma TNF-α, IL-6, MIP-2, and KC Levels
Inflammatory cytokines such as TNF-α and IL-6 have
shown to play key roles in pathophysiology of hepatic IR
injury [15,16]. We have previously shown that in hepatic
I/R, the plasma cytokine levels increase following reper-
fusion, reaching maximal levels between 3 and, 6 hrs of
reperfusion, and that these levels return to baseline after 6
hrs of reperfusion [14]. As such, in this study the cytokine
profile was examined during the first 6 hrs of reperfusion.
In our previous study, we demonstrated that in this model
of hepatic I/R Kupffer cells are the major cellular source of
cytokine production and that plasma cytokines correlated
with liver mRNA of the related cytokines [14]. As such, in
the current study, the plasma cytokine/chemokine levels
were measured using an ELISA. There was a significant
increase in plasma TNF-α level as reperfusion time
increased in both male and female I/R mice compared to
the sham-treated mice (Figure 4B). Minimal levels of TNF-
α were observed in the sham-treated mice (Figure 4B).
Although, no statistically significant difference was
observed between plasma TNF-α levels of male and
female I/R mice (p = 0.4), female TNF-α levels were lower
than those of their male counterparts at 3 and, 6 hrs of
reperfusion (Figure 4A). This data corroborates the
plasma ALT levels, which showed a similar finding.
The plasma IL-6 levels were significantly increased in the
I/R group compared to the sham group (Figure 5). This
difference was also extended into differences between the
two sexes (Figure 5A). There was a significant increase in
plasma IL-6 levels at 1.5 hrs of reperfusion in the female
I/R group compared to the male group. However, this dif-
ference decreased after 3 hrs of reperfusion, and by 6 hrs
of reperfusion, the plasma IL-6 levels in female I/R mice
were significantly lower than their respective male coun-
terparts (Figure 5A). The plasma IL-6 levels in sham mice
were minimal in both male and female group, and no dif-
ference was present between the two sexes (Figure 5B).
The C-X-C chemokines, KC, and MIP-2 are potent neu-
trophil chemoattractants, which are important in hepatic
IR injury [14,16]. In the current study, similar to the above
noted cytokines, a significant increase in MIP-2 levels was
observed in the I/R treated group compared to the sham
group (Figure 6). In particular, there was an increase in
MIP-2 levels at all time-points excluding the zero time-
point. A significant difference between male and female I/
R mice was observed at 3 and, 6 hrs of reperfusion (Figure
6A). Female I/R mice showed significantly lower levels of
MIP-2 compared to the male mice. Although, the plasma
MIP-2 levels in both sham and female sham treated
groups were minimal at all time-points, the female mice
at 6 hrs of reperfusion had a significantly higher level of
MIP-2 than the male counterparts (Figure 6B).
In the current study, the plasma KC levels followed a sim-
ilar pattern of elevation like IL-6 (Figure 7). In particular,
it was observed that female I/R mice had higher levels of
KC than the male at 1.5 and, 3 hrs of reperfusion, which
declined by 6 hrs of reperfusion (Figure 7A). Of particular
interest was that the female sham mice had significantly
higher level of Plasma KC than their male counterparts
(Figure 7B).
Discussion
The importance of sex hormones in modulating both the
innate and adaptive immune responses has been docu-
mented, which is mainly based on experimental studies in
which sex steroids/drugs were administered to ovariect-
omized/castrated animals or tissue cultures. The role of
gender differences in inflammatory cytokine regulation in
response to hepatic I/R has never been examined under
normal pathophysiologic condition. As such, the aim of
this study was to examine the role of gender dimorphism
in inflammatory tissue cytokine response to hepatic IR
under normal pathophysiologic condition without any
artificial sex-steroid interventions. The results of this study
indicated that a statistically significant difference in
cytokine/chemokine production was present between the
two genders, the cytokines were differentially regulated in
response to hepatic I/R, and that the hepatocellular injury
was independent of the chemokine production.
Plasma ALT levels are indicative of hepatic injury. The
data from the current study showed a reperfusion time-
dependent liver injury increase in both sexes. However,
when the responses of the two sexes were compared to
one another, a small to moderate difference (i.e., 17–
20%) in hepatic damage was observed, in that the males
had higher levels of ALT than the females. The difference
did not reach a statistical significance (p = 0.4). This is inJournal of Inflammation 2006, 3:16 http://www.journal-inflammation.com/content/3/1/16
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Immunohistochemical staining of neutrophils in the liver tissue section Figure 3
Immunohistochemical staining of neutrophils in the liver tissue section. Mice were subjected to surgical procedure 
involving 90 min of ischemia followed by 6 hrs of reperfusion. Neutrophils are stained dark brown. Rows A and B correspond 
to the ischemic liver sections, while row C corresponds to the non-ischemic liver of the same animal subjected to hepatic I/R. 
Abbreviations: I = ischemic liver, NI = non-ischemic liver. Images are representative of four liver samples per each time point/
group.
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Time-course of plasma TNF-α levels following various reperfusion times, after the onset of 90 min of ischemia Figure 4
Time-course of plasma TNF-α levels following various reperfusion times, after the onset of 90 min of ischemia. 
"Control" indicates mice that underwent no surgical procedure. "Sham" indicates mice that underwent surgical procedure with 
no vascular occlusion followed by reperfusion, while "I/R" indicates mice that underwent surgical procedure with vascular 
occlusion for 90 min followed by reperfusion for various lengths of time. Values are expressed as mean ± SEM. *P < 0.05 
female group vs. male group (n = 5–9 mice per each time point/group). A: I/R group; B: Sham group.
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Time-course of plasma IL-6 levels following various reperfusion times, after the onset of 90 min of ischemia Figure 5
Time-course of plasma IL-6 levels following various reperfusion times, after the onset of 90 min of ischemia. 
"Control" indicates mice that underwent no surgical procedure. "Sham" indicates mice that underwent surgical procedure with 
no vascular occlusion followed by reperfusion, while "I/R" indicates mice that underwent surgical procedure with vascular 
occlusion for 90 min followed by reperfusion for various lengths of time. Values are expressed as mean ± SEM. *P < 0.05 
female group vs. male group (n = 5–9 mice per each time point/group). A: I/R group; B: Sham group.
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Time-course of plasma MIP-2 levels following various reperfusion times, after the onset of 90 min of ischemia Figure 6
Time-course of plasma MIP-2 levels following various reperfusion times, after the onset of 90 min of ischemia. 
"Control" indicates mice that underwent no surgical procedure. "Sham" indicates mice that underwent surgical procedure with 
no vascular occlusion followed by reperfusion, while "I/R" indicates mice that underwent surgical procedure with vascular 
occlusion for 90 min followed by reperfusion for various lengths of time. Values are expressed as mean ± SEM. *P < 0.05 
female group vs. male group (n = 5–9 mice per each time point/group. A: I/R group; B: Sham group.
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Time-course of plasma KC levels following various reperfusion times, after the onset of 90 min of ischemia Figure 7
Time-course of plasma KC levels following various reperfusion times, after the onset of 90 min of ischemia. 
"Control" indicates mice that underwent no surgical procedure. "Sham" indicates mice that underwent surgical procedure with 
no vascular occlusion followed by reperfusion, while "I/R" indicates mice that underwent surgical procedure with vascular 
occlusion for 90 min followed by reperfusion for various lengths of time. Values are expressed as mean ± SEM. *P < 0.05 
female group vs. male group (n = 5–9 mice per each time point/group. A: I/R group; B: Sham group.
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contrast to previously reported data by Harada et al., who
showed a significant difference in ALT levels, with males
having higher levels of ALT [11,17]. This difference in
results between these two studies may be explained by the
length of reperfusion time and the animal models
applied. In the studies by Harada et al., plasma ALT levels
were measured after 20 hrs of reperfusion, unlike in the
current study in which ALT levels were measured at 0, 1.5,
3, and, 6 hrs of reperfusion. The time-points in the current
study were chosen as the objective was to study the
cytokine/chemokine regulation and its relation to the
hepatic injury. Previously published studies from our lab-
oratory have shown that cytokine/chemokine levels dur-
ing these time-points are maximal and as time progresses
the levels start to decrease, reaching their baseline by 15
hrs of reperfusion [14]. The longer reperfusion time used
in the Harada et al. studies may have allowed for greater
hepatic damage to occur between males and females dur-
ing the late phase of I/R, allowing for a statistical differ-
ence to be noticed. In support of this argument, a recent
study from our laboratory reported a cytokine-independ-
ent hepatic injury during the late phase of liver I/R injury
[13]. In addition, other factors may have influenced the
difference observed, including the estrous cycle and the
animal model used. The animal model used by Harada et
al. was hepatic I/R with liver reduction (i.e., hepatectomy)
whereas our model was a partial hepatic I/R model with-
out hepatectomy [11,17]. A previous study has shown
that hepatectomy induces a marked elevation of circulat-
ing sex steroids, and that estrogen has a potential role in
activating gene expression, which promotes hepatic regen-
eration [18,19], thus allowing for a more prominent sex
difference to be observed, as was seen in the Harada stud-
ies [11,17]. Further, in the current study, female mice had
different levels of estrogen since they were at various
stages of the estrus cycle, as determined by cyto-analysis of
the vaginal preps (data not shown). This is in contrast to
the other studies in which optimal concentrations of sex
steroids were administered to ovariectomized/castrated
animals.
Inflammatory cytokines such as TNF-α and IL-6 have
shown to play key roles in pathophysiology of hepatic I/R
injury [14-16]. Tumor necrosis factor-α is the proximal
cytokine that is expressed following hepatic I/R, and cor-
relates with hepatic reperfusion injury. The data from this
study corroborates this, as it was similar to plasma ALT
levels, TNF-α levels increased with increasing reperfusion
time (Figure 4). When the TNF-α production in response
to hepatic I/R was compared between the male and female
mice, a small to moderate difference (p = 0.3 to 0.7) was
noticed at 1.5, 3 and, 6 hrs of reperfusion, in that the
males had higher levels of plasma TNF-α than their female
counterparts (i.e., 8–20%). This observation was corrobo-
rated with the plasma ALT results. Conflicting data regard-
ing whether there is a sex difference in TNF-α levels have
been reported. In support of our data, Scheingraber et al.
found no significant sex difference in TNF-α level of
female and male patients undergoing major or minor
abdominal surgery [20]. Similarly, Speyer et al. found no
significant difference in TNF-α level between male and
female mice after lipopolysaccharide-induced lung injury
[21]. On the other hand, other studies have noted sex dif-
ferences in TNF-α level [6,22]. The discrepancies between
studies may be attributed to the experimental model
applied, as well as species differences.
In addition to the cytokine TNF-α, the plasma IL-6 levels
were also measured. Interleukin-6 is a multifunctional
cytokine that is both pro-mitogenic and anti-apoptotic for
hepatocytes, and is considered a marker for tissue injury
severity [23,24]. In the current study, a significant differ-
ence in IL-6 levels between sham and hepatic I/R groups
was observed (Figure 5). Initially female I/R mice had
higher levels of IL-6 than males, which began to decline to
lower levels than the males by 6 hrs of reperfusion (Fig-
ures 5A). Based on these observations it appears that
females were primed to respond to hepatic injury, as ini-
tially they generated higher levels of IL-6. This priming
condition may explain why female mice demonstrated
less hepatic damage compared to the males (i.e. lower
plasma ALT levels), and why females in general are some-
what more robust in response to sepsis and trauma than
males [2]. This hypothesis has previously been suggested
by Wichmann et al., who found an enhanced cytokine
response in female mice after hemorrhage shock, com-
pared to male mice [25]. Other studies have also shown a
similar pattern [26]. Further, the initial increased IL-6 lev-
els may be involved in anti-apoptotic actions and may
add further support as to why females showed less hepatic
damage. Teoh et al. reported that IL-6 may be a potential
mediator of the hepatoprotective and pro-proliferative
effects as a result of ischemic preconditioning [23]. More-
over, circulating estrogen may have lead to the decreased
IL-6 levels, suggesting a potential explanation as to why
IL-6 levels decreased in female I/R mice, while it contin-
ued to increase in male I/R mice [27].
The kinetics of chemokine production was examined in
this study. Plasma MIP-2 levels in the sham group were
constant and minimal, while a significant difference was
observed between male and female hepatic I/R groups
(Figure 6). Similar to the above noted cytokines, male I/R
mice had significantly higher level of plasma MIP-2 than
the female I/R counterparts. However, the most striking
observation was the kinetic of KC production in the
female mice. As Figure 7B shows, a significantly high level
of plasma KC was present in the female sham mice at 1.5
hrs of reperfusion, which declined by 6 hrs of reperfusion.
The plasma KC levels of the female sham group were sig-Journal of Inflammation 2006, 3:16 http://www.journal-inflammation.com/content/3/1/16
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nificantly higher than those of the male counterparts at all
time points of the reperfusion (Figure 7B). This response
of the female sham group indicates an inflammatory
response to the trauma induced by abdominal surgery
(i.e., laparotomy), which was not noticeable in the male
sham counterparts (Figure 7B). The heightened produc-
tion of KC in females may be due to circulating estrogen,
although the exact mechanisms by which estrogen exerts
its effects are unknown. During the diestrous and
metestrous stages, there is a marked increase in the
number of leukocytes in the vaginal stroma and lumen,
which denotes the presence of an inflammatory response.
If the mice were at either of these stages of their estrous
cycle, it may have primed KC production, and would
account for the difference observed between male and
female sham mice. To our knowledge, this is a novel
observation that has not been previously reported, and
further study is warranted to examine the regulation of the
cytokine during the estrus cycle and its potential priming
effect in inflammatory response. Specifically studies
examining the different stages of the estrus cycle, as well
as the use of ovariectomized female mice, the use of
female mice administered an estrogen antagonist and the
use of male mice administered estrogen will help eluci-
date estrogen's priming effect and its effect in hepatic IR
injury. The data also suggested that under this experimen-
tal condition, CXC-chemokine production in female in
response to laparotomy was not associated with TNF-α
production since it's level was minute in the plasma of
these sham mice. Further, the study suggested differential
regulation of the two chemokines, i.e., KC, and MIP-2, in
hepatic IR response. The current data regarding the
plasma KC level in the male group is consistent with the
previous reports indicating a constitutive expression of
mRNA KC in the liver and presence of low levels of the
protein in the plasma of male mice subjected to the sham
operation [14,16]. The current study suggests that females
may be primed to respond to injury, since there was a sig-
nificantly greater increase in KC levels in females than the
males. In addition, this study not only underscores the
differential role of gender in cytokine regulation, but also
highlights the importance of gender consideration in
interpretations of the experimental data. The reader needs
to be reminded that the data presented is preliminary and
that further investigation is necessary in order to better
elucidate the differential regulation of IL-6, MIP-2, and
KC, as a result of gender dimorphism during hepatic I/R.
Although the exact mechanism to explain the differences
in cytokine/chemokine levels after hepatic I/R injury is
unknown, it may be postulated that the sex steroid hor-
mones may play a role. In a study by Sener et al., pre-treat-
ment with estradiol decreased levels of TNF-α in the liver
and intestine of septic rats [3]. Estrogen inhibits TNF-α
production both in vivo and in vitro [28-30]. Further,
estrogen at physiological levels reduces IL-6, and MIP-2
production in many cell types, including macrophages
[27,31,32]. Estrogen has also been shown to have an
effect on endothelial nitric oxide (NO), in that it is able to
increase production of NO [33]. An increase in NO would
allow for vasodilatation to the site of hepatic injury and in
turn facilitate reperfusion to the ischemic and surround-
ing tissue, minimizing the degree of tissue hypoxia and
injury. Further, estrogen has strong antioxidant proper-
ties, including inhibition of low-density lipoprotein oxi-
dation, decreased lipoprotein levels, and reduction in
superoxide production [29,33,34]. Moreover, other stud-
ies have also shown that estrogen-receptor knock-out
mice have significantly higher ALT levels than their wild-
type female equivalents [17]. Collectively, these studies
indicate a potential mechanism by which estrogen may
reduce the extent of hepatic I/R injury. Further studies are
required to establish the role of estrogen in hepatic IR by
utilizing estrogen/estrogen receptor antagonists or knock-
out mice.
The present study is the first to demonstrate that under
normal pathophysiologic condition there is a gender-spe-
cific response in cytokine/chemokine regulation as an
inflammatory response to hepatic I/R. Based on the data
presented here, it is evident that cytokine/chemokine reg-
ulation in an innate immune response to hepatic I/R dis-
plays a gender dimorphic response. The study also
highlights the complex nature of I/R injury in which IL-6
and the chemokines MIP-2, and KC do not correlate with
the hepatic injury in a cause-and-effect manner. The cur-
rent findings warrant further investigation into the role of
gender dimorphism and the underlying mechanisms of
hepatic I/R injury during early and late phases of injury,
and in addition, the potential therapeutic role of sex ster-
oids in hepatic injury.
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